263 participants
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-15
- Start Date:
- 2023-06-05
- Completion:
- 2024-08-06
Conditions
- Alzheimer's Disease (AD)
Interventions
- DRUG